tirzepatide surmount-1 percent weight loss 72 weeks Lilly released results for SURMOUNT-2, a trial of in people with T2D and obesity or overweight at weeks: 🔘10 mg: -13.4% BW 🔘15 mg: -15.7% BW ⭐️Important: at Oral tirzepatide: what actually exists,

Key Takeaways Fatigue is common on GLP-1sbut not inevitable Under-eating, electrolyte imbalance, and muscle loss are top culprits Emotional and cognitive stress also play a role Gentle tweaks to food, hydration, and sleep can make a big difference Dont be afraid to ask for blood tests or a dose reassessment Ready for a clearer, structured approach

Nov 26 2019;11(12)doi:10.3390/nu11122878

Metabolic rewiring of bacterial pathogens in response to antibiotic pressurea molecular perspective

Because semaglutide changes how the stomach processes food and medication, its important to know whether it could interfere with how other drugs, like Mucinex, are absorbed or metabolized in the body